GLENMARK PHARMACEUTICALS LTD
11/09/2026 AGM
1
Approve Audited Standalone Financial Statements
For
2
Approve Audited Consolidated Financial Statements
For
3
Approve the Dividend (INR 2.50)
For
4
Re-elect Blanche Saldanha - Non-Executive Director
For
5
Approve Remuneration of Cost Auditor
For
Back
